Billionaire and activist investor Carl Icahn is pushing for a sale of Clorox, the consumer-products conglomerate that owns Durham-based Burt's Bees.
Icahn offered to buy Clorox for $76.50 a share, or more than $10 billion. But he also urged company officials to seek other "strategic buyers" including Procter & Gamble, Kimberly-Clark, Unilever and Colgate-Palmolive.
These potential acquirers could market Clorox's brands more aggressively overseas, Icahn wrote in a letter to Clorox CEO Donald Knauss.
"I would love to have this company," Icahn told CNBC today. But he added that he expects there will be competing offers.


Unilever plans to expand its factory in Raeford that makes a variety of body washes, shampoos and deodorants, adding 65 jobs over the next three years.
The new boss at Burt's Bees made his public debut in the Triangle this week.
GlaxoSmithKline plans to sell 19 of its consumer-health brands, including the controversial Alli weight-loss drug and Goody's, the headache powder invented in Winston-Salem.
John Replogle has stepped down as CEO of Burt's Bees, the personal-care products company based in Durham.
Burt's Bees is worth a bit less, at least on the books of its parent corporation.
A beauty products company is planning a $12 million expansion at its Sanford manufacturing operations and expects to add 140 jobs by early next year.
Burt's Bees, the Durham company that makes lip balms and other natural-care products, released its Social and Environmental report today, highlighting its sustainability efforts and green initiatives.
